As of June 13, 2025, Danameco Medical Joint Stock Corp (DNM.VN) reports a Net Margin of -0.13%.
Net Margin shows the share of revenue that becomes profit after all costs, reflecting overall profitability.
Historical Trend of Danameco Medical Joint Stock Corp's Net Margin
Over recent years, Danameco Medical Joint Stock Corp's Net Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Net Margin |
|---|---|
| 2024-12-31 | -0.13% |
| 2023-12-31 | -25.02% |
| 2022-12-31 | -25.10% |
| 2021-12-31 | 4.93% |
| 2020-12-31 | 5.30% |
This slight downward trend highlights how Danameco Medical Joint Stock Corp manages its overall profitability and cost control over time.
Comparing Danameco Medical Joint Stock Corp's Net Margin to Peers
To better understand Danameco Medical Joint Stock Corp's position, it's useful to compare its Net Margin against industry peers. Below are selected comparisons:
| Company | Net Margin |
|---|---|
| Danameco Medical Joint Stock Corp (DNM.VN) | -0.13% |
| RAYBAN SUN OPTICS INDIA Pvt Ltd (BAUSCHLOMB.NS) | 59.92% |
| Allmed Solutions Ltd (ALMD.TA) | 50.64% |
| SciVision Biotech Inc (1786.TW) | 27.43% |
| Optus Pharmaceutical Co Ltd (131030.KQ) | 12.59% |
| Metabiomed Co Ltd (059210.KQ) | 12.13% |
Compared to its competitors, Danameco Medical Joint Stock Corp's Net Margin is about average compared to peers, reflecting typical industry profitability.